SCHEMA - Cancer Therapy Evaluation Program (CTEP)

Mar 16, 2012 · , including information to support safety issues and the rationale for the proposed starting dose, dose escalation scheme, and regimen chosen. Please also provide information on the mechanism of action, summaries of nonclinical and clinical studies, nonclinical and clinical pharmacokinetics, and major route of elimination. ................
................